Effect of Long Term Inhaled Corticosteroid Therapy on Adrenal Suppression, Growth and Bone Health in Children with Asthma

Overview

Journal BMC Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2019 Nov 6

PMID 31684902

Citations 7

Authors

Anuradha Kwda

Prematilake Gldc

Batuwita Baui

Kannangoda Kasr

Hewagamage Us

Wijeratne S

Lankatilake Kantha

de Silva Ksh

Affiliations

Soon will be listed here.

Abstract

Background: Inhaled corticosteroids (ICS) are the most effective treatment for children with persistent asthma. However adverse effects of ICS on Hypothalamo Pituitary Adrenal (HPA) axis, growth and bone metabolism are a concern. Hence the primary objective of this study was to describe the effects of long term inhaled corticosteroid therapy (ICS) on adrenal function, growth and bone health in children with asthma in comparison to an age and sex matched group of children with asthma who were not on long term ICS. Describing the association between the dose of ICS and duration of therapy on the above parameters were secondary objectives.

Method: Seventy children with asthma on ICS and 70 controls were studied. Diagnosis of asthma in selected patients was reviewed according to the criteria laid down by GINA 2018 guidelines. The estimated adult heights were interpreted relative to their Mid Parental Height (MPH) range. Serum calcium, alkaline phosphatase and vitamin D levels were analyzed in both groups and cortisol value at 30 min following a low dose short synacthen test was obtained from the study group. The average daily dose of ICS (Beclamethasone) was categorized as low, medium and high (100-200, 200-400, > 400 μg /day) respectively according to published literature.

Results: Heights of all children were within the MPH range. There was no statistically significant difference in the bone profiles and vitamin D levels between the two groups (Ca: p = 0.554, vitamin D: p = 0.187) but vitamin D levels were insufficient (< 50 nmol/l) in 34% of cases and 41% of controls. Suppressed cortisol levels were seen in 24%. Doses of ICS were low, medium and high in 56, 32 and 12% of children respectively. The association between adrenal suppression with longer duration of therapy (p < 0.01) and with increasing dose of ICS (p < 0.001) were statistically significant.

Conclusion: ICS had no impact on the growth and bone profiles but its dose and duration were significantly associated with adrenal suppression.

Citing Articles

Urine metabolomics signature reveals novel determinants of adrenal suppression in children taking inhaled corticosteroids to control asthma symptoms.

Tran D, Chen Y, Zheng Y, Hecker J, Hawcutt D, Pirmohamed M Immun Inflamm Dis. 2024; 12(7):e1315.

PMID: 39031511 PMC: 11259003. DOI: 10.1002/iid3.1315.

Hypothalamic-Pituitary-Adrenal Axis Suppression with Inhaled Corticosteroids-Time to Close the Debate?.

Bajpai A Indian J Pediatr. 2024; 91(5):426-427.

PMID: 38233635 DOI: 10.1007/s12098-024-05043-y.

Effect of Long-term Inhaled Corticosteroids on the Hypothalamic-Pituitary-Adrenal Axis in Children with Asthma.

Hema L, Kumar P, Goyal J, Vyas V, Singh K Indian J Pediatr. 2023; 91(5):441-447.

PMID: 37418102 DOI: 10.1007/s12098-023-04706-6.

Accelerating synergistic effects of preconditioned mesenchymal stem cells with Crocin and dexamethasone in pulmonary epithelial cells injury.

Jamshidi V, Halabian R, Saeedi P, Bagheri H, Nobakht Motlagh Ghoochani B Toxicol Res (Camb). 2023; 12(3):369-380.

PMID: 37397913 PMC: 10311171. DOI: 10.1093/toxres/tfad016.

Efficacy of three different budesonide treatments in Chinese preschool children with recurrent wheezing.

Li L, Zhang F, Sun P, Zheng J, Chen T, Huang T Sci Rep. 2022; 12(1):17043.

PMID: 36220847 PMC: 9553874. DOI: 10.1038/s41598-022-21505-9.

References

Pedersen S . Do inhaled corticosteroids inhibit growth in children?. Am J Respir Crit Care Med. 2001; 164(4):521-35. DOI: 10.1164/ajrccm.164.4.2101050. View

Axelsson I, Naumburg E, Prietsch S, Zhang L . Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. Cochrane Database Syst Rev. 2019; 6:CD010126. PMC: 6564081. DOI: 10.1002/14651858.CD010126.pub2. View

Santiago A, Ratzan S . Acute adrenal crisis in an asthmatic child treated with inhaled fluticasone proprionate. Int J Pediatr Endocrinol. 2010; 2010. PMC: 2931373. DOI: 10.1155/2010/749239. View

Della Giustina A, Landi M, Bellini F, Bosoni M, Ferrante G, Onorari M . Vitamin D, allergies and asthma: focus on pediatric patients. World Allergy Organ J. 2015; 7(1):27. PMC: 4363348. DOI: 10.1186/1939-4551-7-27. View

Tanner J, Goldstein H, Whitehouse R . Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child. 1970; 45(244):755-62. PMC: 1647404. DOI: 10.1136/adc.45.244.755. View

Munns C, Shaw N, Kiely M, Specker B, Thacher T, Ozono K . Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Horm Res Paediatr. 2016; 85(2):83-106. DOI: 10.1159/000443136. View

Wright C, Cheetham T . The strengths and limitations of parental heights as a predictor of attained height. Arch Dis Child. 1999; 81(3):257-60. PMC: 1718044. DOI: 10.1136/adc.81.3.257. View

Efthimiou J, Barnes P . Effect of inhaled corticosteroids on bones and growth. Eur Respir J. 1998; 11(5):1167-77. DOI: 10.1183/09031936.98.11051167. View

Demirel F, Kara O, Tepe D, Esen I . Bone mineral density and vitamin D status in children and adolescents with congenital adrenal hyperplasia. Turk J Med Sci. 2015; 44(1):109-14. DOI: 10.3906/sag-1301-114. View

10.

Zollner E, Lombard C, Galal U, Hough F, Irusen E, Weinberg E . Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children. Pediatrics. 2012; 130(6):e1512-9. DOI: 10.1542/peds.2012-1147. View

11.

Arend E, Fischer G, Debiasi M, Schmid H . Inhaled corticosteroid treatment and growth of asthmatic children seen at outpatient clinics. J Pediatr (Rio J). 2006; 82(3):197-203. DOI: 10.2223/JPED.1486. View

12.

Dhawan P, Christakos S . Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBP beta, and the Vitamin D receptor in 24(OH)ase transcription. J Cell Biochem. 2010; 110(6):1314-23. DOI: 10.1002/jcb.22645. View

13.

Dahl R . Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006; 100(8):1307-17. DOI: 10.1016/j.rmed.2005.11.020. View

14.

Drake A, Howells R, Shield J, Prendiville A, Ward P, Crowne E . Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ. 2002; 324(7345):1081-2. PMC: 1123030. DOI: 10.1136/bmj.324.7345.1081. View

15.

Allen D . Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol. 2002; 89(6):537-9. DOI: 10.1016/S1081-1206(10)62097-2. View

16.

ALLEN H, Thong I, Holmes S, Nery L, Wilson K . Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol. 2000; 29(3):188-93. DOI: 10.1002/(sici)1099-0496(200003)29:3<188::aid-ppul6>3.0.co;2-k. View

17.

Heffler E, Madeira L, Ferrando M, Puggioni F, Racca F, Malvezzi L . Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma. J Allergy Clin Immunol Pract. 2018; 6(3):776-781. DOI: 10.1016/j.jaip.2018.01.025. View

18.

Hopp R, Degan J, Phelan J, Lappe J, Gallagher G . Cross-sectional study of bone density in asthmatic children. Pediatr Pulmonol. 1995; 20(3):189-92. DOI: 10.1002/ppul.1950200311. View

19.

Tse S, Kelly H, Litonjua A, Van Natta M, Weiss S, Tantisira K . Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D. J Allergy Clin Immunol. 2012; 130(1):53-60.e4. PMC: 3387323. DOI: 10.1016/j.jaci.2012.04.005. View

20.

Kurahashi I, Matsunuma A, Kawane T, Abe M, Horiuchi N . Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3. Endocrine. 2002; 17(2):109-18. DOI: 10.1385/ENDO:17:2:109. View